Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Commercial vaccine name</td><td class="align_center">Safety profile</td><td class="align_center">Persistence duration of antibodies</td><td class="align_center">Cost</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Rift Valley Fever (live)</td><td class="align_center">Cause abortion in pregnant ewes <br/>Cause teratogenic effects<br/>Cause significant level of viraemia <br/>Risk of reversion to virulence</td><td class="align_center">Long-term immunity <br/>Single dose</td><td class="align_center">Low price</td></tr><tr><td class="align_center" colspan="4"><hr/></td></tr><tr><td class="align_left">RVF Clone13</td><td class="align_center">Safe in pregnancy<br/>Very low viraemia<br/>Risk of genetic reassortment <br/>Restricted to endemic zones</td><td class="align_center">Short shelf-life <br/>Single dose<br/>Lon-term immunity</td><td class="align_center">Low price</td></tr><tr><td class="align_center" colspan="4"><hr/></td></tr><tr><td class="align_left">Rift Valley Fever (inactivated)</td><td class="align_center">Safe in pregnancy<br/>Can be used during outbreaks <br/>Can be used in low risk zones</td><td class="align_center">Booster dose is required <br/>Annual revaccination <br/>Not practical in routine vaccination</td><td class="align_center">High cost</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Safety and efficacy profile of commercial vaccines against RFV [<a href="/journals/jir/2016/7346294/#B48">13</a>].

Journal of Immunology Research

tab3

Table 3

Table 3: Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study 